QUANTITATIVE METHODS FOR MEASURING PATIENT PREFERENCES: PILOT STUDY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F24%3A00382175" target="_blank" >RIV/68407700:21460/24:00382175 - isvavai.cz</a>

Výsledek na webu

<a href="https://doi.org/10.14311/CTJ.2024.4.02" target="_blank" >https://doi.org/10.14311/CTJ.2024.4.02</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.14311/CTJ.2024.4.02" target="_blank" >10.14311/CTJ.2024.4.02</a>

Jazyk výsledku

angličtina

Název v původním jazyce

QUANTITATIVE METHODS FOR MEASURING PATIENT PREFERENCES: PILOT STUDY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER

Popis výsledku v původním jazyce

This pilot study examines patient preferences in patients with localized prostate cancer using quantitative methods for measuring Discrete Choice Experiment (DCE) and Best-Worst Scaling (BWS) type 3. The study focuses on key attributes that may influence patients' treatment decisions. Patients chose one of two or three hypothetical treatment scenarios based on key attributes: risk of erectile dysfunction; urinary incontinence; other side effects; transport to hospital and return to normal activities. Additionally, patients evaluated both methods in terms of difficulty and satisfaction using a Likert scale. Results show that the most important attribute for patients with localized prostate cancer is the risk of erectile dysfunction (36.0%, 29.8%), followed by the risk of urinary incontinence (24.9%, 23.0%). In both attributes, patients wanted to avoid the worst levels and vice versa. The results of preferred attributes did not differ between methods. Patients found the Discrete Choice Experiment method less difficult and were more satisfied with it. This research suggests that quantitative approaches, such as DCE and BWS, can be valuable tools for better understanding patient preferences and integrating them into personalized treatment decision-making.

Název v anglickém jazyce

QUANTITATIVE METHODS FOR MEASURING PATIENT PREFERENCES: PILOT STUDY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER

Popis výsledku anglicky

This pilot study examines patient preferences in patients with localized prostate cancer using quantitative methods for measuring Discrete Choice Experiment (DCE) and Best-Worst Scaling (BWS) type 3. The study focuses on key attributes that may influence patients' treatment decisions. Patients chose one of two or three hypothetical treatment scenarios based on key attributes: risk of erectile dysfunction; urinary incontinence; other side effects; transport to hospital and return to normal activities. Additionally, patients evaluated both methods in terms of difficulty and satisfaction using a Likert scale. Results show that the most important attribute for patients with localized prostate cancer is the risk of erectile dysfunction (36.0%, 29.8%), followed by the risk of urinary incontinence (24.9%, 23.0%). In both attributes, patients wanted to avoid the worst levels and vice versa. The results of preferred attributes did not differ between methods. Patients found the Discrete Choice Experiment method less difficult and were more satisfied with it. This research suggests that quantitative approaches, such as DCE and BWS, can be valuable tools for better understanding patient preferences and integrating them into personalized treatment decision-making.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30304 - Public and environmental health

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Lékař a technika – Clinician and Technology

ISSN

0301-5491

e-ISSN

2336-5552

Svazek periodika

54

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

9

Strana od-do

119-127

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-105001106522